Astellas Pharma
ALPMYDrugs in Pipeline
206
Phase 3 Programs
114
Upcoming Catalysts
5
Next Catalyst
Dec 2026
Market Overview
Stock performance and key metrics
5 upcoming, 0 past
OPT-80
Clostridium Difficile
Setidegrasib
Pancreatic Cancer
daclizumab
Kidney Transplantation
nitrazepam
Sleep Initiation and Maintenance Disorders
FK506E (modified release tacrolimus)
Liver Transplantation
Famotidine
Gastroesophageal Reflux
avacincaptad pegol
Geographic Atrophy
febuxostat
Gout
Capsaicin 8%
Diabetic Peripheral Neuropathy
Mirabegron
Neurogenic Detrusor Overactivity
Micafungin
Candidiasis, Oral
ipragliflozin
Diabetes Mellitus
RSD1235
Atrial Fibrillation
ASP0113
Allogeneic Hematopoietic Cell Transplant
pudexacianinium chloride
Intraoperative Ureter Visualization
roxadustat
Hemodialysis Chronic Kidney Disease Patients With Anemia
tolterodine
Urinary Bladder, Overactive
Solifenacin succinate
Urinary Bladder, Overactive
YM178
Urinary Bladder, Overactive
nateglinide
Type 2 Diabetes Mellitus
Darbepoetin alfa
Anemia in Chronic Kidney Disease in Non-dialysis Patients
Fezolinetant
Hot Flashes
ASP8825
Restless Legs Syndrome
DPP-4 inhibitor
Type 2 Diabetes Mellitus
YM060
Irritable Bowel Syndrome
Enzalutamide
Progressive Metastatic Prostate Cancer
Cyclosporine
Heart Diseases
ASP1585
Chronic Kidney Disease Patients on Hemodialysis With Hyperphosphatemia
Certolizumab pegol
Rheumatoid Arthritis
ASP1941
Type 2 Diabetes Mellitus
Tacrolimus Cream
Psoriasis
YM150
Arthroplasty, Replacement, Knee
tacrolimus ointment
Dermatitis, Atopic
FK949E
Bipolar Disorder
CDP870
Active Rheumatoid Arthritis
linaclotide
Irritable Bowel Syndrome With Constipation (IBS-C)
Prograf
Liver Transplantation
isavuconazole
Aspergillosis
FK506
Keratoconjunctivitis
tamsulosin hydrochloride/solifenacin succinate fixed dose combination (0.4 mg/6 mg)
Lower Urinary Tract Symptoms
MMF
Kidney Transplantation
OSI-906
Adrenocortical Carcinoma
Gilteritinib
Advanced Solid Tumors
peficitinib
Psoriasis
FK199B
Sleep Initiation and Maintenance Disorders
tamsulosin hydrochloride OCAS 0.4 mg
Benign Prostatic Hyperplasia
caspofungin
Candidiasis, Oral
degarelix
Prostatic Neoplasms
YM443
Indigestion
Solifenacin succinate suspension
Urinary Bladder, Overactive
Tacrolimus capsule
Myasthenia Gravis
Tacrolimus ointment 0.1%
Dermatitis, Atopic
mirabegron 25 mg
Urinary Bladder Diseases
basiliximab
Kidney Transplantation
tolterodine ER
Urinary Bladder, Overactive
Corticosteroids
Liver Transplantation
Midostaurin
Acute Myeloid Leukemia
regadenoson
Coronary Artery Disease (CAD)
Ipragliflozin L-proline
Type 2 Diabetes Mellitus
Sevelamer hydrochloride
Hyperphosphatemia
cyclosporine microemulsion
Kidney Transplantation
MR4
Kidney Transplantation
Tamuslosin
Urinary Tract Diseases
LoDAC (Low Dose Cytarabine)
Leukemia, Acute Myeloid (AML)
Interferon alfacon-1
Hepatitis C
Sulfonylurea
Type 2 Diabetes Mellitus
DA
Chronic Kidney Disease
methylprednisolone and prednisone
Kidney Transplantation
Tacrolimus capsules
Lupus Nephritis
overencapsulated caffeine
Coronary Artery Disease (CAD)
Tamusulosin
Urinary Tract Diseases
Etanercept
Rheumatoid Arthritis
QUTENZA
Painful Diabetic Peripheral Neuropathy (PDPN)
Plaebo
Rheumatoid Arthritis (RA)
FK506MR capsule
Liver Transplantation
Voriconazole
Aspergillosis
Tacrolimus, modified release
Kidney Transplantation
FK506E
Heart Transplantation
Alefacept
Psoriatic Arthritis
Epoetin alfa
Anemia
Ra223
Prostate Cancer
Exisulind
NSCLC
Enfortumab vedotin
Metastatic Urothelial Cancer
Fidaxomicin oral suspension
Clostridium Difficile-associated Diarrhea (CDAD)
ASP2138
Gastric Adenocarcinoma
Prednisolone
Metastatic Castration Resistant Prostate Cancer
fluconazole
Invasive Candidiasis
TRK-100STP high dose
Chronic Renal Failure
Rabbit Anti-Human Thymocyte Globulin
Pancreas-Kidney Transplantation
Goserelin
Prostate Cancer
G-CSF
AML With FLT3 Mutation
ONO-5920
Involutional Osteoporosis
Regadenoson; Optison
Coronary Artery Disease
Folinic acid (leucovorin or local equivalent)
Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer
Minodronic acid hydrate
Involutional Osteoporosis
YM177
Post Operative Pain
micafungin (Mycamine)
Fungemia
VESIcare®
Urinary Bladder, Overactive
CZP
Rheumatoid Arthritis
Liposomal Amphotericin B
Candidiasis
YM529 / ONO-5920
Osteoporosis
Ramosetron
Vomiting
Advagraf
Heart Transplantation
FK506MR
Kidney Transplantation
Simulect
Kidney Transplantation
Prograf-XL
Liver Transplantation
Zolpidem MR
Sleep Initiation and Maintenance Disorders
alpha glucosidase inhibitor
Type 2 Diabetes Mellitus
leuprorelin acetate
Prostate Cancer
Tacrolimus modified-release
Liver Transplantation
zolbetuximab
Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer
Steroids
De Novo Kidney Transplantation
Androgen deprivation therapy (ADT)
Metastatic Hormone Sensitive Prostate Cancer
Tacrolimus (Prograf®)
Rheumatoid Arthritis
ASP1650
Incurable Platinum Refractory Germ Cell Tumors
ASP0456
Chronic Constipation
Midazolam
Acute Myeloid Leukemia
Erlotinib
NSCLC
tamsulosin hydrochloride
Lower Urinary Tract Symptoms
YM872 (zonampanel), t-PA (alteplase)
Acute Ischemic Stroke
Bicalutamide
Prostate Cancer
ASP4070
Rhinitis, Allergic, Seasonal
ASP4901
Benign Prostate Hyperplasia
Tacrolimus Inhalation Aerosol
Asthma
ASP2998
Locally Advanced or Metastatic Malignant Solid Tumors
tacrolimus modified release (MR)
Liver Transplantation
Rapamycin
Type 1 Diabetes
Tacrolimus Ointment 0.03%
Dermatitis, Atopic
ASP5541
Prostate Cancer
Mycophenolate Mofetil (MMF)
Kidney Transplantation
Solifenacin
Overactive Bladder
ASP8062
Fibromyalgia
Leuprolide
Prostate Cancer
ASP0819
Fibromyalgia
ASP9831
Non-Alcoholic Steatohepatitis
Isavuconazonium sulfate
Invasive Mucormycosis
FK788
Hepatitis C
OSI-461
Chronic Lymphocytic Leukemia
AGS-1C4D4
Carcinoma, Pancreatic Ductal
ASP2151
Herpes Genitalis
ASP1517
Anemia in Chronic Kidney Disease Patients Not on Dialysis
ASP8477
Post-Herpetic Neuralgia (PHN)
TPC
Metastatic Breast Cancer
ASP7991
Secondary Hyperparathyroidism
ASP1707
Endometriosis
ASP7517
Acute Myeloid Leukemia (AML)
ASP5094
Rheumatoid Arthritis (RA)
Enzalutamide 40 MG
Ovarian Cancer
ASP4345
Schizophrenia
FK614
Diabetes Mellitus
ASKP1240
Psoriasis
XNW27011
Pancreatic Adenocarcinoma Metastatic
steroids, monoclonal anti-IL2R antibody
Hepatitis C
GnRH analog
Prostate Cancer
YM872 (zonampanel)
Cerebrovascular Accident
YM543
Diabetes Mellitus Type 2
MDV3100
Prostate Cancer
Androgen Deprivation
Prostate Cancer
enfortumab vedotin (EV)
Carcinoma, Transitional Cell
ASP8232
Diabetes Mellitus
Idarubicin
Acute Myeloid Leukemia
OSI-211 (Liposomal Lurtotecan)
SCLC
Abiraterone
Metastatic Prostate Cancer
MA09-hRPE
Stargardt's Macular Dystrophy
ASK8007
Rheumatoid Arthritis
ASP1570
Advanced Solid Tumors
ELIGARD
Prostate Cancer
trametinib
Prostate Cancer
FK463
Candidiasis
hydrocortisone acetate ointment 1%
Atopic Dermatitis
Clobetasol cream
Vulvar Lichen Sclerosus
Flutamide
Castration-resistant Prostate Cancer
ASP6294
Bladder Pain Syndrome
FK778
Kidney Transplantation
ASP546C
Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma
ASP7962
Osteoarthritis of the Knee
ASP2246
Chronic Ischemic Stroke
Beraprost
Renal Insufficiency, Chronic
MK-3475
Bladder Cancer
ASP8302
Underactive Bladder
epirubicin
CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction
AGS-16C3F
Metastatic Renal Cell Carcinoma
Enzalutamide capsule
Prostate Cancer
quetiapine extended release (XR)
Major Depressive Disorder
Erlotinib Hydrochloride
Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
ASP3082
Metastatic/Locally Advanced Non-Small-Cell Lung Cancer
Valacyclovir hydrochloride
Herpes Zoster
ASP3550
Prostatic Neoplasms
warfarin
Atrial Fibrillation
ADT+Docetaxel+Enzalutamide
Prostate Cancer
VCL-CB01
Acute Lymphoblastic Leukemia
ASP3652
Chronic Abacterial Prostatitis
ASP1128
Acute Kidney Injury (AKI)
linsitinib
Advanced Solid Tumors
Trimethoprim and sulfamethoxazole
Kidney Diseases
YM 155
Prostate Cancer
Reldesemtiv
Chronic Obstructive Pulmonary Disease (COPD)
gadofoveset trisodium
Myocardial Ischemia
scAAV9.U7.ACCA
Duchenne Muscular Dystrophy
CP-461
Crohn's Disease
Methylprednisolone
X-Linked Myotubular Myopathy
Tacrolimus prolonged release
Intestine Transplantation
Bleselumab
Kidney Transplantation
YM155
Lung Cancer
Lexiscan
Cardiovascular Diseases
Anti-IL2R AB
Liver Transplantation
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
OPT-80 | Phase 3 | Clostridium Difficile | - | - |
Setidegrasib | Phase 3 | Pancreatic Cancer | - | - |
daclizumab | Phase 3 | Kidney Transplantation | - | - |
nitrazepam | Phase 3 | Sleep Initiation and Maintenance Disorders | - | - |
FK506E (modified release tacrolimus) | Phase 3 | Liver Transplantation | - | - |
Famotidine | Phase 3 | Gastroesophageal Reflux | - | - |
avacincaptad pegol | Phase 3 | Geographic Atrophy | - | - |
febuxostat | Phase 3 | Gout | - | - |
Capsaicin 8% | Phase 3 | Diabetic Peripheral Neuropathy | - | - |
Mirabegron | Phase 3 | Neurogenic Detrusor Overactivity | - | - |
Micafungin | Phase 3 | Candidiasis, Oral | - | - |
ipragliflozin | Phase 3 | Diabetes Mellitus | - | - |
RSD1235 | Phase 3 | Atrial Fibrillation | - | - |
ASP0113 | Phase 3 | Allogeneic Hematopoietic Cell Transplant | - | - |
pudexacianinium chloride | Phase 3 | Intraoperative Ureter Visualization | - | - |
roxadustat | Phase 3 | Hemodialysis Chronic Kidney Disease Patients With Anemia | - | - |
tolterodine | Phase 3 | Urinary Bladder, Overactive | - | - |
Solifenacin succinate | Phase 3 | Urinary Bladder, Overactive | - | - |
YM178 | Phase 3 | Urinary Bladder, Overactive | - | - |
nateglinide | Phase 3 | Type 2 Diabetes Mellitus | - | - |
Darbepoetin alfa | Phase 3 | Anemia in Chronic Kidney Disease in Non-dialysis Patients | - | - |
Fezolinetant | Phase 3 | Hot Flashes | - | - |
ASP8825 | Phase 3 | Restless Legs Syndrome | - | - |
DPP-4 inhibitor | Phase 3 | Type 2 Diabetes Mellitus | - | - |
YM060 | Phase 3 | Irritable Bowel Syndrome | - | - |
Enzalutamide | Phase 3 | Progressive Metastatic Prostate Cancer | - | - |
Cyclosporine | Phase 3 | Heart Diseases | - | - |
ASP1585 | Phase 3 | Chronic Kidney Disease Patients on Hemodialysis With Hyperphosphatemia | - | - |
Certolizumab pegol | Phase 3 | Rheumatoid Arthritis | - | - |
ASP1941 | Phase 3 | Type 2 Diabetes Mellitus | - | - |
Tacrolimus Cream | Phase 3 | Psoriasis | - | - |
YM150 | Phase 3 | Arthroplasty, Replacement, Knee | - | - |
tacrolimus ointment | Phase 3 | Dermatitis, Atopic | - | - |
FK949E | Phase 3 | Bipolar Disorder | - | - |
CDP870 | Phase 3 | Active Rheumatoid Arthritis | - | - |
linaclotide | Phase 3 | Irritable Bowel Syndrome With Constipation (IBS-C) | - | - |
Prograf | Phase 3 | Liver Transplantation | - | - |
isavuconazole | Phase 3 | Aspergillosis | - | - |
FK506 | Phase 3 | Keratoconjunctivitis | - | - |
tamsulosin hydrochloride/solifenacin succinate fixed dose combination (0.4 mg/6 mg) | Phase 3 | Lower Urinary Tract Symptoms | - | - |
MMF | Phase 3 | Kidney Transplantation | - | - |
OSI-906 | Phase 3 | Adrenocortical Carcinoma | - | - |
Gilteritinib | Phase 3 | Advanced Solid Tumors | - | - |
peficitinib | Phase 3 | Psoriasis | - | - |
FK199B | Phase 3 | Sleep Initiation and Maintenance Disorders | - | - |
tamsulosin hydrochloride OCAS 0.4 mg | Phase 3 | Benign Prostatic Hyperplasia | - | - |
caspofungin | Phase 3 | Candidiasis, Oral | - | - |
degarelix | Phase 3 | Prostatic Neoplasms | - | - |
YM443 | Phase 3 | Indigestion | - | - |
Solifenacin succinate suspension | Phase 3 | Urinary Bladder, Overactive | - | - |
Tacrolimus capsule | Phase 3 | Myasthenia Gravis | - | - |
Tacrolimus ointment 0.1% | Phase 3 | Dermatitis, Atopic | - | - |
mirabegron 25 mg | Phase 3 | Urinary Bladder Diseases | - | - |
basiliximab | Phase 3 | Kidney Transplantation | - | - |
tolterodine ER | Phase 3 | Urinary Bladder, Overactive | - | - |
Corticosteroids | Phase 3 | Liver Transplantation | - | - |
Midostaurin | Phase 3 | Acute Myeloid Leukemia | - | - |
regadenoson | Phase 3 | Coronary Artery Disease (CAD) | - | - |
Ipragliflozin L-proline | Phase 3 | Type 2 Diabetes Mellitus | - | - |
Sevelamer hydrochloride | Phase 3 | Hyperphosphatemia | - | - |
cyclosporine microemulsion | Phase 3 | Kidney Transplantation | - | - |
MR4 | Phase 3 | Kidney Transplantation | - | - |
Tamuslosin | Phase 3 | Urinary Tract Diseases | - | - |
LoDAC (Low Dose Cytarabine) | Phase 3 | Leukemia, Acute Myeloid (AML) | - | - |
Interferon alfacon-1 | Phase 3 | Hepatitis C | - | - |
Sulfonylurea | Phase 3 | Type 2 Diabetes Mellitus | - | - |
DA | Phase 3 | Chronic Kidney Disease | - | - |
methylprednisolone and prednisone | Phase 3 | Kidney Transplantation | - | - |
Tacrolimus capsules | Phase 3 | Lupus Nephritis | - | - |
overencapsulated caffeine | Phase 3 | Coronary Artery Disease (CAD) | - | - |
Tamusulosin | Phase 3 | Urinary Tract Diseases | - | - |
Etanercept | Phase 3 | Rheumatoid Arthritis | - | - |
QUTENZA | Phase 3 | Painful Diabetic Peripheral Neuropathy (PDPN) | - | - |
Plaebo | Phase 3 | Rheumatoid Arthritis (RA) | - | - |
FK506MR capsule | Phase 3 | Liver Transplantation | - | - |
Voriconazole | Phase 3 | Aspergillosis | - | - |
Tacrolimus, modified release | Phase 3 | Kidney Transplantation | - | - |
FK506E | Phase 3 | Heart Transplantation | - | - |
Alefacept | Phase 3 | Psoriatic Arthritis | - | - |
Epoetin alfa | Phase 3 | Anemia | - | - |
Ra223 | Phase 3 | Prostate Cancer | - | - |
Exisulind | Phase 3 | NSCLC | - | - |
Enfortumab vedotin | Phase 3 | Metastatic Urothelial Cancer | - | - |
Fidaxomicin oral suspension | Phase 3 | Clostridium Difficile-associated Diarrhea (CDAD) | - | - |
ASP2138 | Phase 3 | Gastric Adenocarcinoma | - | - |
Prednisolone | Phase 3 | Metastatic Castration Resistant Prostate Cancer | - | - |
fluconazole | Phase 3 | Invasive Candidiasis | - | - |
TRK-100STP high dose | Phase 3 | Chronic Renal Failure | - | - |
Rabbit Anti-Human Thymocyte Globulin | Phase 3 | Pancreas-Kidney Transplantation | - | - |
Goserelin | Phase 3 | Prostate Cancer | - | - |
G-CSF | Phase 3 | AML With FLT3 Mutation | - | - |
ONO-5920 | Phase 3 | Involutional Osteoporosis | - | - |
Regadenoson; Optison | Phase 3 | Coronary Artery Disease | - | - |
Folinic acid (leucovorin or local equivalent) | Phase 3 | Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer | - | - |
Minodronic acid hydrate | Phase 3 | Involutional Osteoporosis | - | - |
YM177 | Phase 3 | Post Operative Pain | - | - |
micafungin (Mycamine) | Phase 3 | Fungemia | - | - |
VESIcare® | Phase 3 | Urinary Bladder, Overactive | - | - |
CZP | Phase 3 | Rheumatoid Arthritis | - | - |
Liposomal Amphotericin B | Phase 3 | Candidiasis | - | - |
YM529 / ONO-5920 | Phase 3 | Osteoporosis | - | - |
Ramosetron | Phase 3 | Vomiting | - | - |
Advagraf | Phase 3 | Heart Transplantation | - | - |
FK506MR | Phase 3 | Kidney Transplantation | - | - |
Simulect | Phase 3 | Kidney Transplantation | - | - |
Prograf-XL | Phase 3 | Liver Transplantation | - | - |
Zolpidem MR | Phase 3 | Sleep Initiation and Maintenance Disorders | - | - |
alpha glucosidase inhibitor | Phase 3 | Type 2 Diabetes Mellitus | - | - |
leuprorelin acetate | Phase 3 | Prostate Cancer | - | - |
Tacrolimus modified-release | Phase 3 | Liver Transplantation | - | - |
zolbetuximab | Phase 3 | Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer | - | - |
Steroids | Phase 3 | De Novo Kidney Transplantation | - | - |
Androgen deprivation therapy (ADT) | Phase 3 | Metastatic Hormone Sensitive Prostate Cancer | - | - |
Tacrolimus (Prograf®) | Phase 3 | Rheumatoid Arthritis | - | - |
ASP1650 | Phase 2 | Incurable Platinum Refractory Germ Cell Tumors | - | - |
ASP0456 | Phase 2 | Chronic Constipation | - | - |
Midazolam | Phase 2 | Acute Myeloid Leukemia | - | - |
Erlotinib | Phase 2 | NSCLC | - | - |
tamsulosin hydrochloride | Phase 2 | Lower Urinary Tract Symptoms | - | - |
YM872 (zonampanel), t-PA (alteplase) | Phase 2 | Acute Ischemic Stroke | - | - |
Bicalutamide | Phase 2 | Prostate Cancer | - | - |
ASP4070 | Phase 2 | Rhinitis, Allergic, Seasonal | - | - |
ASP4901 | Phase 2 | Benign Prostate Hyperplasia | - | - |
Tacrolimus Inhalation Aerosol | Phase 2 | Asthma | - | - |
ASP2998 | Phase 2 | Locally Advanced or Metastatic Malignant Solid Tumors | - | - |
tacrolimus modified release (MR) | Phase 2 | Liver Transplantation | - | - |
Rapamycin | Phase 2 | Type 1 Diabetes | - | - |
Tacrolimus Ointment 0.03% | Phase 2 | Dermatitis, Atopic | - | - |
ASP5541 | Phase 2 | Prostate Cancer | - | - |
Mycophenolate Mofetil (MMF) | Phase 2 | Kidney Transplantation | - | - |
Solifenacin | Phase 2 | Overactive Bladder | - | - |
ASP8062 | Phase 2 | Fibromyalgia | - | - |
Leuprolide | Phase 2 | Prostate Cancer | - | - |
ASP0819 | Phase 2 | Fibromyalgia | - | - |
ASP9831 | Phase 2 | Non-Alcoholic Steatohepatitis | - | - |
Isavuconazonium sulfate | Phase 2 | Invasive Mucormycosis | - | - |
FK788 | Phase 2 | Hepatitis C | - | - |
OSI-461 | Phase 2 | Chronic Lymphocytic Leukemia | - | - |
AGS-1C4D4 | Phase 2 | Carcinoma, Pancreatic Ductal | - | - |
ASP2151 | Phase 2 | Herpes Genitalis | - | - |
ASP1517 | Phase 2 | Anemia in Chronic Kidney Disease Patients Not on Dialysis | - | - |
ASP8477 | Phase 2 | Post-Herpetic Neuralgia (PHN) | - | - |
TPC | Phase 2 | Metastatic Breast Cancer | - | - |
ASP7991 | Phase 2 | Secondary Hyperparathyroidism | - | - |
ASP1707 | Phase 2 | Endometriosis | - | - |
ASP7517 | Phase 2 | Acute Myeloid Leukemia (AML) | - | - |
ASP5094 | Phase 2 | Rheumatoid Arthritis (RA) | - | - |
Enzalutamide 40 MG | Phase 2 | Ovarian Cancer | - | - |
ASP4345 | Phase 2 | Schizophrenia | - | - |
FK614 | Phase 2 | Diabetes Mellitus | - | - |
ASKP1240 | Phase 2 | Psoriasis | - | - |
XNW27011 | Phase 2 | Pancreatic Adenocarcinoma Metastatic | - | - |
steroids, monoclonal anti-IL2R antibody | Phase 2 | Hepatitis C | - | - |
GnRH analog | Phase 2 | Prostate Cancer | - | - |
YM872 (zonampanel) | Phase 2 | Cerebrovascular Accident | - | - |
YM543 | Phase 2 | Diabetes Mellitus Type 2 | - | - |
MDV3100 | Phase 2 | Prostate Cancer | - | - |
Androgen Deprivation | Phase 2 | Prostate Cancer | - | - |
enfortumab vedotin (EV) | Phase 2 | Carcinoma, Transitional Cell | - | - |
ASP8232 | Phase 2 | Diabetes Mellitus | - | - |
Idarubicin | Phase 2 | Acute Myeloid Leukemia | - | - |
OSI-211 (Liposomal Lurtotecan) | Phase 2 | SCLC | - | - |
Abiraterone | Phase 2 | Metastatic Prostate Cancer | - | - |
MA09-hRPE | Phase 2 | Stargardt's Macular Dystrophy | - | - |
ASK8007 | Phase 2 | Rheumatoid Arthritis | - | - |
ASP1570 | Phase 2 | Advanced Solid Tumors | - | - |
ELIGARD | Phase 2 | Prostate Cancer | - | - |
trametinib | Phase 2 | Prostate Cancer | - | - |
FK463 | Phase 2 | Candidiasis | - | - |
hydrocortisone acetate ointment 1% | Phase 2 | Atopic Dermatitis | - | - |
Clobetasol cream | Phase 2 | Vulvar Lichen Sclerosus | - | - |
Flutamide | Phase 2 | Castration-resistant Prostate Cancer | - | - |
ASP6294 | Phase 2 | Bladder Pain Syndrome | - | - |
FK778 | Phase 2 | Kidney Transplantation | - | - |
ASP546C | Phase 2 | Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma | - | - |
ASP7962 | Phase 2 | Osteoarthritis of the Knee | - | - |
ASP2246 | Phase 2 | Chronic Ischemic Stroke | - | - |
Beraprost | Phase 2 | Renal Insufficiency, Chronic | - | - |
MK-3475 | Phase 2 | Bladder Cancer | - | - |
ASP8302 | Phase 2 | Underactive Bladder | - | - |
epirubicin | Phase 2 | CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction | - | - |
AGS-16C3F | Phase 2 | Metastatic Renal Cell Carcinoma | - | - |
Enzalutamide capsule | Phase 2 | Prostate Cancer | - | - |
quetiapine extended release (XR) | Phase 2 | Major Depressive Disorder | - | - |
Erlotinib Hydrochloride | Phase 2 | Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | - | - |
ASP3082 | Phase 2 | Metastatic/Locally Advanced Non-Small-Cell Lung Cancer | - | - |
Valacyclovir hydrochloride | Phase 2 | Herpes Zoster | - | - |
ASP3550 | Phase 2 | Prostatic Neoplasms | - | - |
warfarin | Phase 2 | Atrial Fibrillation | - | - |
ADT+Docetaxel+Enzalutamide | Phase 2 | Prostate Cancer | - | - |
VCL-CB01 | Phase 2 | Acute Lymphoblastic Leukemia | - | - |
ASP3652 | Phase 2 | Chronic Abacterial Prostatitis | - | - |
ASP1128 | Phase 2 | Acute Kidney Injury (AKI) | - | - |
linsitinib | Phase 2 | Advanced Solid Tumors | - | - |
Trimethoprim and sulfamethoxazole | Phase 2 | Kidney Diseases | - | - |
YM 155 | Phase 2 | Prostate Cancer | - | - |
Reldesemtiv | Phase 2 | Chronic Obstructive Pulmonary Disease (COPD) | - | - |
gadofoveset trisodium | Phase 2 | Myocardial Ischemia | - | - |
scAAV9.U7.ACCA | Phase 2 | Duchenne Muscular Dystrophy | - | - |
CP-461 | Phase 2 | Crohn's Disease | - | - |
Methylprednisolone | Phase 2 | X-Linked Myotubular Myopathy | - | - |
Tacrolimus prolonged release | Phase 2 | Intestine Transplantation | - | - |
Bleselumab | Phase 2 | Kidney Transplantation | - | - |
YM155 | Phase 2 | Lung Cancer | - | - |
Lexiscan | Phase 2 | Cardiovascular Diseases | - | - |
Anti-IL2R AB | Phase 2 | Liver Transplantation | - | - |
geographic atrophy
1 drug in this indication
Rhinitis, Allergic, Seasonal
1 drug in this indication
Asthma
1 drug in this indication
Benign Prostate Hyperplasia
1 drug in this indication
Pancreatic Cancer
1 drug in this indication
Rheumatoid Arthritis
1 drug in this indication
Locally advanced/metastatic bladder cancer
1 drug in this indication
Clostridium Difficile
1 drug in this indication
Kidney Transplantation
1 drug in this indication
Incurable Platinum Refractory Germ Cell Tumors
1 drug in this indication
Post Operative Pain
1 drug in this indication
Fungemia
1 drug in this indication
NSCLC
1 drug in this indication
Urinary Bladder, Overactive
1 drug in this indication
Acute Ischemic Stroke
1 drug in this indication
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Full breakdown — the signals behind the verdict
Frequently asked questions
What is in Astellas Pharma's drug pipeline?→
CatalystAlert tracks 206 drug candidates in Astellas Pharma's (ALPMY) pipeline across Phase 3, Phase 2. Its lead program is OPT-80 (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Astellas Pharma's next FDA catalyst?→
Astellas Pharma's (ALPMY) next tracked catalyst is a Phase 2 expected December 16, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track ALPMY biotech catalysts?→
Add ALPMY to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Astellas Pharma's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.